Therapeutic Potential of Targeting PAK Signaling
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
75-88
Author(s):
William Senapedis, Marsha Crochiere, Erkan Baloglu and Yosef Landesman
Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5172-5186
Author(s):
Biswajit Mukherjee, Lopamudra Dutta, Laboni Mondal, Niladri Shekhar Dey, Samrat Chakraborty, Ruma Maji and Tapan Kumar Shaw
Nano Traditional Chinese Medicine: Current Progresses and Future Challenges
Journal:
Current Drug Targets
Volume:
16
Page:
1548-1562
Author(s):
Yi Huang, Yinglan Zhao, Fang Liu and Songqing Liu
Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5017-5028
Author(s):
Yuting Wu, Cheng Huang, Xiaoming Meng and Jun Li
Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5066-5072
Author(s):
Akiko Shiotani, Yoshihiko Fujita and Kazuto Nishio
Editorial (Thematic Issue: Harmful and Beneficial Effect of Aspirin on Gastrointestinal Tract)
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5047-5048
Author(s):
Katsunori Iijima and Angel Lanas
Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5056-5065
Author(s):
Katsunori Iijima and Tooru Shimosegawa
The GABAergic System and the Gastrointestinal Physiopathology
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
4996-5016
Author(s):
Michelangelo Auteri, Maria Grazia Zizzo and Rosa Serio
Prevention of Upper Gastrointestinal Ulcer and Complications in Low-Dose Aspirin Users
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5082-5088
Author(s):
Kentaro Sugano
Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5108-5115
Author(s):
Wen-Kuan Huang, Hui-Tzu Tu and Lai-Chu See